查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球体外膜氧合（ECMO）设备市场按产品类型、模式、患者类型、应用和最终用户划分－预测至2030年
市场调查报告书
商品编码
1858521

全球体外膜氧合（ECMO）设备市场按产品类型、模式、患者类型、应用和最终用户划分－预测至2030年

ECMO Machines Market by Product (ECMO Machines, Components ), Modality, Patient Type, Application, End User - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 252 Pages | 订单完成后即时交付

价格

全球 ECMO 设备市场预计将从 2025 年的 6.5 亿美元成长到 2030 年的 8.6 亿美元，预测期内复合年增长率为 5.8%。

调查范围
调查年度 2024-2030
基准年 2024
预测期 2025-2030
单元 10亿美元
部分 产品类型、模式、患者类型、应用程式、最终用户
目标区域 北美、欧洲、亚太地区及其他地区

近年来，体外膜氧合（ECMO）设备已从笨重、人工操作繁琐的系统发展成为紧凑、自动化且高效的平台。新一代ECMO整合了即时监控、自动流量调节和基于人工智慧的氧合控制功能，减少了持续的人工干预。 Getinge AB和美敦力等主要企业引领可携式ECMO的创新，促进了院内和院间病患的顺利转运。部分系统现已配备无线连接和云端基础监测功能，使专家能够远端追踪患者数据。改进的离心式帮浦和聚甲基戊烯（PMP）氧合器提高了设备的耐用性，并减少了溶血和血栓形成等併发症。

ECMO设备市场-IMG1

此外，抗凝血治疗管理的创新降低了出血风险，出血一直是体外膜氧合（ECMO）患者面临的一大挑战。这些技术突破提高了病患的生存率，使资源有限的医院也能更容易使用ECMO，并促进了ECMO在已开发和新兴医疗市场的广泛应用。

依产品类型划分，体外膜氧合（ECMO）设备市场可分为组件和ECMO设备两部分。 2024年，组件部分在全球ECMO设备市场中占据最大份额。由于急性呼吸窘迫症候群（ARDS）、心臟麻痹和多重器官衰竭的发生率不断上升，ECMO的使用在全球三级医院中日益普及。每次ECMO手术都需要消耗氧合器、帮浦、管路、控制器和插管。即使是短期ECMO，氧合器和插管等组件也属于一次性使用，而帮浦需要精确匹配，并且通常在每次手术后进行升级。疫情后的准备工作将增加ECMO的使用频率，从而确保组件的稳定週转。虽然设备本身保持不变，但手术数量的增加将推动组件部分呈指数级增长。

ECMO市场依患者类型分为成人、儿童和新生儿三个细分市场。 2024年，成人患者占据ECMO设备市场最大的市场。新冠肺炎疫情凸显了ECMO在治疗成人重症呼吸衰竭中的作用。尖峰时段，接受ECMO治疗的患者多为严重急性呼吸窘迫症候群（ARDS）的成人患者。即使在疫情急性期结束后，许多倖存者仍出现长期肺损伤、肺纤维化和其他呼吸系统併发症，导致重症患者对ECMO的需求增加。新冠肺炎併发症，如心肌炎和病毒性肺炎后遗症，也主要影响成人，从而推动了该年龄层对ECMO的需求。疫情期间，全球医院扩大了ECMO基础设施，尤其是在成人加护病房（ICU），这对设备的普及产生了长期影响。由于这种长期影响，2024年成人患者仍将占据ECMO市场最大的份额。

预计在预测期内，北美将占据体外膜氧合（ECMO）设备市场最大的份额。北美，尤其是美国和加拿大，拥有高度发展的医疗保健生态系统，包括一流的医院、重症监护室和专科医疗中心。这些设施能够支援ECMO等复杂且资源密集技术。大型三级医院和教学医院通常是ECMO手术的中心，其先进的重症监护室和训练有素的多学科团队确保了对患者的有效管理。与新兴地区相比，北美医院拥有足够的财力和基础设施来投资昂贵的ECMO设备并进行高效维护。此外，数位医疗系统（包括先进的监测工具）的深度整合确保了ECMO的安全管理。这种基础设施的完善使得ECMO得以大规模应用，提高了治疗的可及性并改善了患者的生存率。因此，完善的医疗保健网路在巩固北美在ECMO设备市场的领先地位方面发挥核心作用。

本报告分析了全球 ECMO 设备市场，并提供了关键驱动因素和限制因素、竞争格局和未来趋势的资讯。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 主要发现

  • ECMO设备市场概览
  • 亚太地区体外膜氧合（ECMO）机市场（按产品和国家划分）（2024 年）
  • ECMO设备市场：地域成长机会
  • ECMO设备市场，区域组成（2023-2030年）
  • ECMO设备市场：新兴国家与已开发国家对比

第五章 市场概览

  • 介绍
  • 市场动态
    • 司机
    • 抑制因素
    • 机会
    • 任务
  • 影响客户业务的趋势/颠覆性因素
  • 定价分析
    • 主要企业按类型分類的平均销售价格
    • 各地区平均销售价格趋势
  • 价值链分析
  • 供应链分析
  • 生态系分析
  • 投资和资金筹措方案
  • 技术分析
    • 主要技术
    • 互补技术
    • 邻近技术
  • 产业趋势
    • 在非传统护理环境中，体外膜氧合（ECMO）的应用日益增加。
    • 体外膜氧合（ECMO）在小儿科和新生儿护理的应用日益广泛
    • ECMO卓越中心及区域化转型
    • ECMO模拟训练与远距ECMO计画的发展
  • 专利分析
  • 贸易分析
    • HS编码901890的进口数据
    • HS编码901890的出口数据
  • 重大会议和活动（2025-2026）
  • 案例研究分析
  • 监管环境
    • 监管分析
    • 监管机构、政府机构和其他组织
  • 波特五力分析
  • 主要相关利益者和采购标准
  • 未满足的需求/最终用户期望
  • 邻近市场分析
  • 人工智慧/生成式人工智慧对体外膜氧合（ECMO）设备市场的影响
    • 介绍
    • 生成式人工智慧在体外膜氧合（ECMO）设备市场的市场潜力
    • 人工智慧应用案例
    • 主要企业采用人工智慧
    • ECMO设备市场中生成式人工智慧的未来
  • 2025年美国关税对体外膜氧合（ECMO）设备市场的影响
    • 主要关税税率
    • 价格影响分析
    • 对各国/地区的主要影响
    • 对终端用户产业的影响

第六章 ECMO设备市场：依产品划分

  • 介绍
  • 成分
    • 氧气发生器
    • 泵浦
    • 控制器
    • 套管
    • 配件
  • 装置

第七章 ECMO设备市场依模式划分

  • 介绍
  • 静脉-静脉体外膜氧合（VV-ECMO）
  • 静脉-动脉体外膜氧合（VA-ECMO）
  • 动静脉体外膜氧合（ECMO）

第八章：依病患类型分類的体外膜氧合（ECMO）设备市场

  • 介绍
  • 成年患者
  • 儿科患者
  • 新生

第九章 ECMO设备市场：依应用领域划分

  • 介绍
  • 呼吸系统应用
  • 心臟应用
  • 体外循环心肺復苏

第十章 ECMO设备市场（依最终用户划分）

  • 介绍
  • 医院
  • 学术研究机构
  • 专科诊所

第十一章 ECMO设备市场（按地区划分）

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 亚太宏观经济展望
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 亚太其他地区
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中东和非洲
  • 海湾合作委员会国家

第十二章 竞争格局

  • 概述
  • 主要参与企业的策略/优势
  • 收入分析（2020-2024）
  • 市占率分析（2024 年）
  • 企业评估矩阵：主要企业（2024）
  • 公司评估矩阵：Start-Ups/中小企业（2024 年）
  • 公司估值和财务指标
  • 品牌/产品对比
  • 竞争场景

第十三章：公司简介

  • 主要企业
    • GETINGE
    • MEDTRONIC
    • TERUMO CORPORATION
    • FRESENIUS MEDICAL CARE AG
    • LIVANOVA PLC
    • NIPRO
    • WEIGAO GROUP CO., LTD.
    • ABBOTT
    • MICROPORT SCIENTIFIC CORPORATION
    • EUROSETS
  • 其他公司
    • SPECTRUM MEDICAL
    • SENKO MEDICAL INSTRUMENT MFG. CO., LTD.
    • CHALICE MEDICAL LTD.
    • MAGASSIST CO., LTD.
    • BRAILE BIOMEDICA
    • GIZMOMED PRIVATE LIMITED
    • ORIGEN BIOMEDICAL, INC.
    • ABIOMED
    • ANDOCOR
    • JIANGSU STMED TECHNOLOGY CO., LTD.
    • CARDIOQUIP
    • CBM LIFEMOTION
    • CHANGZHOU KANGXIN MEDICAL INSTRUMENTS
    • GENTHERM

第十四章附录

Product Code: MD 3966

The ECMO machines market is projected to reach USD 0.86 billion by 2030 from USD 0.65 billion in 2025, at a CAGR of 5.8% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsGlobal ECMO Machines Market, by Product, Modality, Patient Type, Application, End User
Regions coveredNorth America, Europe, APAC, RoW

In recent years, ECMO machines have evolved from bulky, manual-intensive systems to compact, automated, and highly efficient platforms. Next-generation ECMO integrates real-time monitoring, automated flow adjustments, and artificial intelligence (AI)-driven oxygenation control to reduce the need for constant manual intervention. Companies such as Getinge AB and Medtronic are leading in portable ECMO innovations, enabling smoother inter-hospital and intra-hospital patient transfers. Some systems now feature wireless connectivity and cloud-based monitoring, allowing specialists to track remote patient data. Improved centrifugal pumps and polymethyl pentene (PMP) oxygenators enhance durability and reduce complications such as hemolysis or clot formation.

ECMO Machines Market - IMG1

Moreover, innovations in anticoagulation management reduce the risks of bleeding, a historical challenge for ECMO patients. These technological leaps improve patient survival and make ECMO more user-friendly for hospitals with limited staff, driving wider adoption across developed and emerging healthcare markets.

Based on product, the market of ECMO machines is divided into components and ECMO machines. In 2024, the components segment held the largest share of the global ECMO machines market. With the rising incidence of acute respiratory distress syndrome (ARDS), cardiac arrest, and multi-organ failure, ECMO usage has expanded globally across tertiary hospitals. Each ECMO procedure consumes oxygenators, pumps, tubing sets, controllers, and cannulas. Even in short-term ECMO, components like oxygenators and cannulas are single-use, while pumps require precise compatibility and often get upgraded with each procedure. Post-pandemic preparedness further contributes to higher ECMO use, ensuring steady turnover of components. Unlike the machine itself, which remains constant, the increasing number of procedures fuels exponential growth in the component segment.

Based on patient type, the ECMO market has been categorized into adults, pediatrics and neonates. In 2024, adults held the largest market share in the ECMO machines market. The COVID-19 pandemic highlighted ECMO's role in treating severe respiratory failure in adults. During the peak, most ECMO-supported cases were adults with severe ARDS. Even after the acute pandemic phase, many survivors experienced long-term pulmonary damage, fibrosis, and other respiratory complications that increased ECMO utilization in critical cases. Post-COVID-19 complications like myocarditis and post-viral pneumonia also primarily affect adults, contributing to higher demand for ECMO in this age group. Hospitals worldwide expanded ECMO infrastructure during the pandemic, with a focus on adult ICUs, leaving a long-term impact on equipment adoption. This legacy effect ensured that adults continued to account for the largest ECMO market share in 2024.

North America is expected to account for the largest share of the ECMO machines market during the forecast period. North America, particularly the US and Canada, benefits from a highly advanced healthcare ecosystem equipped with top-tier hospitals, critical care units, and specialized medical centers. These facilities can support sophisticated and resource-intensive technologies such as ECMO. Large tertiary hospitals and academic medical centers often serve as hubs for ECMO procedures, offering advanced ICUs and trained multidisciplinary teams that ensure effective patient management. In contrast to emerging regions, North American hospitals possess the financial and infrastructural capacity to invest in expensive ECMO equipment and maintain it efficiently. Furthermore, strong integration of digital health systems, including advanced monitoring tools, ensures safe ECMO management. This infrastructure readiness makes it feasible for ECMO adoption at scale, enhancing accessibility and increasing survival outcomes. As a result, the well-developed healthcare network plays a central role in reinforcing North America's leadership in the ECMO machines market.

A breakdown of the primary participants (supply-side) for the ECMO machines market referred to in this report is provided below:

  • By Company Type: Tier 1: 34%, Tier 2: 38%, and Tier 3: 28%
  • By Designation: C Level: 26%, Director Level: 35%, and Others: 39%
  • By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5%

Prominent players in the ECMO machines market are Fresenius Medical Care AG & Co. KGaA (Germany), Getinge AB (Sweden), Medtronic (Ireland), Terumo Corporation (Japan), and LivaNova PLC (UK).

Research Coverage

The report evaluates the ECMO machines market and estimates the market size and future growth potential based on various segments, including product, modality, patient type, application, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will assist the market leader/new entrants with data on the nearest approximations of the revenue numbers for the overall ECMO machines market and the subsegments. The report will assist stakeholders in understanding the competitive landscape and gain further insights into better positioning their businesses and making appropriate go-to-market strategies. The report assists the stakeholders in understanding the market pulse and gives them data on influential drivers, hindrances, obstacles, and opportunities in the market.

This report provides insights into the following points:

  • Analysis of key drivers (Increasing prevalence of cardiovascular and respiratory diseases, Growing adoption of ECMO in lung transplantation procedures), restraints (Complications associated with ECMO, High cost of ECMO procedures), opportunities (Increasing survival rates with ECMO), and challenges (Shortage of skilled professionals, Eligibility issues for ECMO)
  • Product Launches/Innovations: Comprehensive details about product launches and anticipated trends in the global ECMO machines market
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by product, modality, patient type, application, end user, and region
  • Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global ECMO machines market
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global ECMO machines market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ECMO MACHINES MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: ECMO MACHINES MARKET, BY PRODUCT AND COUNTRY (2024)
  • 4.3 ECMO MACHINES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 ECMO MACHINES MARKET, REGIONAL MIX, 2023-2030
  • 4.5 ECMO MACHINES MARKET: EMERGING VS. DEVELOPED ECONOMIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing prevalence of cardiovascular and respiratory diseases
      • 5.2.1.2 Growing adoption of ECMO in lung transplantation procedures
      • 5.2.1.3 Rise in ECMO centers worldwide
      • 5.2.1.4 Technological advancements in ECMO machines
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Complications associated with ECMO
      • 5.2.2.2 High cost of ECMO procedures
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing survival rates with ECMO
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled professionals
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.4 PRICING ANALYSIS
    • 5.4.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE
    • 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 TECHNOLOGY ANALYSIS
    • 5.9.1 KEY TECHNOLOGIES
      • 5.9.1.1 Advanced oxygenator design
      • 5.9.1.2 High-efficiency blood pumps
    • 5.9.2 COMPLEMENTARY TECHNOLOGIES
      • 5.9.2.1 Advanced hemodynamic monitoring systems
      • 5.9.2.2 Ventilators
    • 5.9.3 ADJACENT TECHNOLOGIES
      • 5.9.3.1 Wearable Artificial Lungs (WALs)
      • 5.9.3.2 Perfusion systems
  • 5.10 INDUSTRY TRENDS
    • 5.10.1 GROWING ADOPTION OF ECMO IN NON-TRADITIONAL CARE SETTINGS
    • 5.10.2 INCREASING USE OF ECMO IN PEDIATRIC AND NEONATAL CARE
    • 5.10.3 SHIFT TOWARD ECMO CENTERS OF EXCELLENCE AND REGIONALIZATION
    • 5.10.4 GROWTH OF ECMO SIMULATION TRAINING AND TELE-ECMO PROGRAMS
  • 5.11 PATENT ANALYSIS
  • 5.12 TRADE ANALYSIS
    • 5.12.1 IMPORT DATA FOR HS CODE 901890
    • 5.12.2 EXPORT DATA FOR HS CODE 901890
  • 5.13 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.14 CASE STUDY ANALYSIS
    • 5.14.1 CASE STUDY 1: IMPROVED SURVIVAL RATES IN US USING ECMO
    • 5.14.2 CASE STUDY 2: NEONATAL ECMO PROGRAM IN UK
    • 5.14.3 CASE STUDY 3: MOBILE ECMO TRANSPORT SERVICE IN GERMANY
  • 5.15 REGULATORY LANDSCAPE
    • 5.15.1 REGULATORY ANALYSIS
      • 5.15.1.1 North America
        • 5.15.1.1.1 US
        • 5.15.1.1.2 Canada
      • 5.15.1.2 Europe
        • 5.15.1.2.1 Germany
        • 5.15.1.2.2 France
        • 5.15.1.2.3 UK
      • 5.15.1.3 Asia Pacific
        • 5.15.1.3.1 China
        • 5.15.1.3.2 Japan
        • 5.15.1.3.3 India
      • 5.15.1.4 Latin America
        • 5.15.1.4.1 Brazil
        • 5.15.1.4.2 Mexico
      • 5.15.1.5 Middle East & Africa
        • 5.15.1.5.1 South Africa
        • 5.15.1.5.2 GCC Countries
    • 5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.16 PORTER'S FIVE FORCES ANALYSIS
    • 5.16.1 BARGAINING POWER OF SUPPLIERS
    • 5.16.2 BARGAINING POWER OF BUYERS
    • 5.16.3 THREAT OF NEW ENTRANTS
    • 5.16.4 THREAT OF SUBSTITUTES
    • 5.16.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.17.2 BUYING CRITERIA
  • 5.18 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.19 ADJACENT MARKET ANALYSIS
  • 5.20 IMPACT OF AI/GEN AI ON ECMO MACHINES MARKET
    • 5.20.1 INTRODUCTION
    • 5.20.2 MARKET POTENTIAL OF GEN AI ON ECMO MACHINES MARKET
    • 5.20.3 AI USE CASES
    • 5.20.4 KEY COMPANIES IMPLEMENTING AI
    • 5.20.5 FUTURE OF GEN AI IN ECMO MACHINES MARKET
  • 5.21 IMPACT OF 2025 US TARIFF ON ECMO MACHINES MARKET
    • 5.21.1 KEY TARIFF RATES
    • 5.21.2 PRICE IMPACT ANALYSIS
    • 5.21.3 KEY IMPACT ON COUNTRY/REGION
      • 5.21.3.1 US
      • 5.21.3.2 Europe
      • 5.21.3.3 Asia Pacific
    • 5.21.4 IMPACT ON END-USE INDUSTRIES

6 ECMO MACHINES MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 COMPONENTS
    • 6.2.1 OXYGENATORS
      • 6.2.1.1 Significantly less priming volume associated with PMP oxygenators to boost demand
    • 6.2.2 PUMPS
      • 6.2.2.1 Pivotal role played by centrifugal blood pumps in adult extracorporeal life support to support market growth
    • 6.2.3 CONTROLLERS
      • 6.2.3.1 Ability of controllers to allow operators of ECMO circuits to adjust settings as needed to drive demand
    • 6.2.4 CANNULAS
      • 6.2.4.1 Importance of cannulas in optimizing ECMO flows to boost market
    • 6.2.5 ACCESSORIES
  • 6.3 MACHINES
    • 6.3.1 ADVANTAGES SUCH AS TIMELY INTERVENTION IN CASES OF RESPIRATORY AND CARDIAC EMERGENCIES TO FUEL GROWTH

7 ECMO MACHINES MARKET, BY MODALITY

  • 7.1 INTRODUCTION
  • 7.2 VENOVENOUS ECMO
    • 7.2.1 LOWER INCIDENCE OF NEUROLOGIC COMPLICATIONS AND LACK OF ARTERIAL COMPROMISE TO BOOST GROWTH
  • 7.3 VENOARTERIAL ECMO
    • 7.3.1 INCREASING INCIDENCE OF HEART-LUNG FAILURE TO DRIVE GROWTH
  • 7.4 ARTERIOVENOUS ECMO
    • 7.4.1 PORTABILITY OF ARTERIOVENOUS ECMO MACHINES TO DRIVE DEMAND

8 ECMO MACHINES MARKET, BY PATIENT TYPE

  • 8.1 INTRODUCTION
  • 8.2 ADULT PATIENTS
    • 8.2.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE USE OF ECMO IN ADULT PATIENTS
  • 8.3 PEDIATRIC PATIENTS
    • 8.3.1 RECENT ADVANCES IN ECMO TO BOOST MARKET GROWTH
  • 8.4 NEONATES
    • 8.4.1 INCREASING UTILIZATION OF ECMO TO MANAGE NEONATES WITH CARDIAC AND RESPIRATORY FAILURE TO SUPPORT GROWTH

9 ECMO MACHINES MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 RESPIRATORY APPLICATIONS
    • 9.2.1 INCREASING CASES OF ACUTE RESPIRATORY DISTRESS SYNDROME, PNEUMONIA, AND INFLUENZA TO SPUR GROWTH
  • 9.3 CARDIAC APPLICATIONS
    • 9.3.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES WORLDWIDE TO SUPPORT GROWTH
  • 9.4 EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION
    • 9.4.1 GROWING CLINICAL EVIDENCE SUGGESTING IMPROVED SURVIVAL RATES AND NEUROLOGICAL OUTCOMES TO FUEL MARKET

10 ECMO MACHINES MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS
    • 10.2.1 GROWING USE OF ECMO FOR MANAGING CRITICAL CONDITIONS TO DRIVE MARKET
  • 10.3 ACADEMIC & RESEARCH INSTITUTIONS
    • 10.3.1 INCREASING MEDICAL COLLEGES AND RESEARCH FACILITIES INVESTING IN ECMO SYSTEMS TO FOSTER GROWTH
  • 10.4 SPECIALTY CLINICS
    • 10.4.1 RISING NEED FOR ADVANCED, LIFE-SAVING INTERVENTIONS TO AID GROWTH

11 ECMO MACHINES MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 US to account for largest share of North American market
    • 11.2.3 CANADA
      • 11.2.3.1 Implementation of ABF model in Canadian hospitals to drive market growth
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 Increasing volume of ECMO procedures to drive market growth in Germany
    • 11.3.3 FRANCE
      • 11.3.3.1 Rising healthcare spending to drive market growth in France
    • 11.3.4 UK
      • 11.3.4.1 Significant investment in healthcare to support adoption of advanced medical technologies like ECMO
    • 11.3.5 ITALY
      • 11.3.5.1 High burden of CVDs to contribute to growth of ECMO machines market in Italy
    • 11.3.6 SPAIN
      • 11.3.6.1 High adoption of advanced technologies to drive market growth in Spain
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 JAPAN
      • 11.4.2.1 Favorable healthcare infrastructure in Japan to drive market growth
    • 11.4.3 CHINA
      • 11.4.3.1 Large patient population and government-backed critical care infrastructure expansion to fuel growth
    • 11.4.4 INDIA
      • 11.4.4.1 Growing applications and rising adoption of ECMO to drive market growth in India
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Advanced healthcare infrastructure and early ECMO adoption to position South Korea as leading regional market
    • 11.4.6 AUSTRALIA
      • 11.4.6.1 Rising respiratory and cardiac complications, coupled with aging population, to fuel ECMO adoption
    • 11.4.7 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Rising adoption of ECMO as bridge to heart and lung transplantation to drive market growth in Brazil
    • 11.5.3 MEXICO
      • 11.5.3.1 High burden of CVDs in country to drive market growth in Mexico
    • 11.5.4 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 INCREASING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH IN MIDDLE EAST & AFRICA
    • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.7 GCC COUNTRIES
    • 11.7.1 RISING INVESTMENTS IN ADVANCED HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
    • 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.3 REVENUE ANALYSIS, 2020-2024
  • 12.4 MARKET SHARE ANALYSIS, 2024
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Region footprint
      • 12.5.5.3 Product footprint
      • 12.5.5.4 Application footprint
      • 12.5.5.5 End-user footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 12.6.5.1 Detailed list of key startups/SMEs
      • 12.6.5.2 Competitive benchmarking of startups/SMEs
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
    • 12.7.1 FINANCIAL METRICS
    • 12.7.2 COMPANY VALUATION
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES & APPROVALS
    • 12.9.2 DEALS
    • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 GETINGE
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product launches
        • 13.1.1.3.2 Expansions
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Right to win
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses & competitive threats
    • 13.1.2 MEDTRONIC
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products offered
      • 13.1.2.3 MnM view
        • 13.1.2.3.1 Right to win
        • 13.1.2.3.2 Strategic choices
        • 13.1.2.3.3 Weaknesses & competitive threats
    • 13.1.3 TERUMO CORPORATION
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Deals
        • 13.1.3.3.2 Expansions
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Right to win
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses & competitive threats
    • 13.1.4 FRESENIUS MEDICAL CARE AG
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Deals
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Right to win
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses & competitive threats
    • 13.1.5 LIVANOVA PLC
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products offered
      • 13.1.5.3 MnM view
        • 13.1.5.3.1 Right to win
        • 13.1.5.3.2 Strategic choices
        • 13.1.5.3.3 Weaknesses & competitive threats
    • 13.1.6 NIPRO
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products offered
    • 13.1.7 WEIGAO GROUP CO., LTD.
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products offered
    • 13.1.8 ABBOTT
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Product approvals
    • 13.1.9 MICROPORT SCIENTIFIC CORPORATION
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products offered
    • 13.1.10 EUROSETS
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products offered
  • 13.2 OTHER PLAYERS
    • 13.2.1 SPECTRUM MEDICAL
    • 13.2.2 SENKO MEDICAL INSTRUMENT MFG. CO., LTD.
    • 13.2.3 CHALICE MEDICAL LTD.
    • 13.2.4 MAGASSIST CO., LTD.
    • 13.2.5 BRAILE BIOMEDICA
    • 13.2.6 GIZMOMED PRIVATE LIMITED
    • 13.2.7 ORIGEN BIOMEDICAL, INC.
    • 13.2.8 ABIOMED
    • 13.2.9 ANDOCOR
    • 13.2.10 JIANGSU STMED TECHNOLOGY CO., LTD.
    • 13.2.11 CARDIOQUIP
    • 13.2.12 CBM LIFEMOTION
    • 13.2.13 CHANGZHOU KANGXIN MEDICAL INSTRUMENTS
    • 13.2.14 GENTHERM

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 ECMO MACHINES MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2020-2024
  • TABLE 3 ECMO MACHINES MARKET: RISK ASSESSMENT
  • TABLE 4 ECMO MACHINES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 5 AVERAGE COST OF ECMO, BY COUNTRY, 2024 (USD)
  • TABLE 6 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024 (USD)
  • TABLE 7 AVERAGE SELLING PRICE TREND OF ECMO MACHINES, BY REGION, 2022-2024 (USD)
  • TABLE 8 ECMO MACHINES MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 9 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 10 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 11 ECMO MACHINES MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ECMO MACHINES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP TWO PRODUCTS (%)
  • TABLE 19 KEY BUYING CRITERIA FOR TOP TWO PRODUCTS
  • TABLE 20 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 21 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR ECMO MACHINES
  • TABLE 22 ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 23 COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 24 COMPONENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 25 EXAMPLES OF OXYGENATORS
  • TABLE 26 OXYGENATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 27 EXAMPLES OF PUMPS
  • TABLE 28 PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 29 EXAMPLES OF CONTROLLERS
  • TABLE 30 CONTROLLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 EXAMPLES OF CANNULAS
  • TABLE 32 CANNULAS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 EXAMPLES OF ACCESSORIES
  • TABLE 34 ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 EXAMPLES OF MACHINES
  • TABLE 36 MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 MACHINES MARKET, BY REGION, 2023-2030 (UNITS)
  • TABLE 38 ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 39 VENOVENOUS ECMO MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 VENOARTERIAL ECMO MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 ARTERIOVENOUS ECMO MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 COMMON INDICATIONS FOR ECMO IN NEONATES, PEDIATRIC PATIENTS, AND ADULT PATIENTS
  • TABLE 43 ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 44 ECMO MACHINES MARKET FOR ADULT PATIENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 ECMO MACHINES MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 46 ECMO MACHINES MARKET FOR NEONATES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 48 ECMO MACHINES MARKET FOR RESPIRATORY APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 ECMO MACHINES MARKET FOR CARDIAC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 ECMO MACHINES MARKET FOR EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 52 ECMO MACHINES MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 53 ECMO MACHINES MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 ECMO MACHINES MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 ECMO MACHINES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 56 NORTH AMERICA: ECMO MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 NORTH AMERICA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 58 NORTH AMERICA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 59 NORTH AMERICA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 60 NORTH AMERICA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 61 NORTH AMERICA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 63 US: MACROECONOMIC INDICATORS
  • TABLE 64 US: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 65 US: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 66 US: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 67 US: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 68 US: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 69 US: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 70 CANADA: MACROECONOMIC INDICATORS
  • TABLE 71 CANADA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 72 CANADA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 73 CANADA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 74 CANADA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 75 CANADA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 76 CANADA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 77 EUROPE: ECMO MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 78 EUROPE: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 79 EUROPE: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 80 EUROPE: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 81 EUROPE: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 82 EUROPE: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 83 EUROPE: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 84 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 85 GERMANY: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 86 GERMANY: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 87 GERMANY: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 88 GERMANY: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 89 GERMANY: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 90 GERMANY: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 91 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 92 FRANCE: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 93 FRANCE: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 94 FRANCE: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 95 FRANCE: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 96 FRANCE: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 97 FRANCE: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 98 UK: MACROECONOMIC INDICATORS
  • TABLE 99 UK: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 100 UK: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 101 UK: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 102 UK: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 103 UK: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 104 UK: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 105 ITALY: MACROECONOMIC INDICATORS
  • TABLE 106 ITALY: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 107 ITALY: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 108 ITALY: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 109 ITALY: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 110 ITALY: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 111 ITALY: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 112 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 113 SPAIN: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 114 SPAIN: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 115 SPAIN: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 116 SPAIN: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 117 SPAIN: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 118 SPAIN: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 119 REST OF EUROPE: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 120 REST OF EUROPE: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 121 REST OF EUROPE: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 122 REST OF EUROPE: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 123 REST OF EUROPE: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 124 REST OF EUROPE: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: ECMO MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 126 ASIA PACIFIC: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 132 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 133 JAPAN: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 134 JAPAN: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 135 JAPAN: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 136 JAPAN: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 137 JAPAN: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 138 JAPAN: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 139 CHINA: MACROECONOMIC INDICATORS
  • TABLE 140 CHINA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 141 CHINA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 142 CHINA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 143 CHINA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 144 CHINA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 145 CHINA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 146 INDIA: MACROECONOMIC INDICATORS
  • TABLE 147 INDIA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 148 INDIA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 149 INDIA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 150 INDIA: ECMO MACHINES MARKET, PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 151 INDIA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 152 INDIA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 153 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 154 SOUTH KOREA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 155 SOUTH KOREA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 156 SOUTH KOREA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 157 SOUTH KOREA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 158 SOUTH KOREA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 159 SOUTH KOREA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 160 AUSTRALIA: MACROECONOMIC INDICATORS
  • TABLE 161 AUSTRALIA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 162 AUSTRALIA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 163 AUSTRALIA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 164 AUSTRALIA: ECMO MACHINES MARKET, PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 165 AUSTRALIA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 166 AUSTRALIA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 167 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 168 REST OF ASIA PACIFIC: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 169 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 170 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 171 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 172 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 173 LATIN AMERICA: ECMO MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 174 LATIN AMERICA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 175 LATIN AMERICA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 176 LATIN AMERICA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 177 LATIN AMERICA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 178 LATIN AMERICA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 179 LATIN AMERICA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 180 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 181 BRAZIL: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 182 BRAZIL: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 183 BRAZIL: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 184 BRAZIL: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 185 BRAZIL: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 186 BRAZIL: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 187 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 188 MEXICO: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 189 MEXICO: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 190 MEXICO: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 191 MEXICO: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 192 MEXICO: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 193 MEXICO: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 194 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 195 REST OF LATIN AMERICA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 196 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 197 REST OF LATIN AMERICA: ECMO MACHINES MARKET, PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 198 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 199 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 200 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 201 MIDDLE EAST & AFRICA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 202 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 203 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 204 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 205 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 206 GCC COUNTRIES: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 207 GCC COUNTRIES: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 208 GCC COUNTRIES: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 209 GCC COUNTRIES: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 210 GCC COUNTRIES: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 211 GCC COUNTRIES: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 212 KEY DEVELOPMENTS IN ECMO MACHINES MARKET, JANUARY 2021-SEPTEMBER 2025
  • TABLE 213 ECMO MACHINES MARKET: DEGREE OF COMPETITION
  • TABLE 214 ECMO MACHINES MARKET: REGION FOOTPRINT
  • TABLE 215 ECMO MACHINES MARKET: PRODUCT FOOTPRINT
  • TABLE 216 ECMO MACHINES MARKET: APPLICATION FOOTPRINT
  • TABLE 217 ECMO MACHINES MARKET: END-USER FOOTPRINT
  • TABLE 218 ECMO MACHINES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 219 ECMO MACHINES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY REGION AND APPLICATION
  • TABLE 220 ECMO MACHINES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 221 ECMO MACHINES MARKET: DEALS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 222 ECMO MACHINES MARKET: EXPANSIONS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 223 GETINGE: COMPANY OVERVIEW
  • TABLE 224 GETINGE: PRODUCTS OFFERED
  • TABLE 225 GETINGE: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2025
  • TABLE 226 GETINGE: EXPANSIONS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 227 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 228 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 229 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 230 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 231 TERUMO CORPORATION: DEALS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 232 TERUMO CORPORATION: EXPANSIONS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 233 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW
  • TABLE 234 FRESENIUS MEDICAL CARE AG: PRODUCTS OFFERED
  • TABLE 235 FRESENIUS MEDICAL CARE AG: DEALS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 236 LIVANOVA PLC: COMPANY OVERVIEW
  • TABLE 237 LIVANOVA PLC: PRODUCTS OFFERED
  • TABLE 238 NIPRO: COMPANY OVERVIEW
  • TABLE 239 NIPRO: PRODUCTS OFFERED
  • TABLE 240 WEIGAO GROUP CO., LTD.: COMPANY OVERVIEW
  • TABLE 241 WEIGAO GROUP CO., LTD.: PRODUCTS OFFERED
  • TABLE 242 ABBOTT: COMPANY OVERVIEW
  • TABLE 243 ABBOTT: PRODUCTS OFFERED
  • TABLE 244 ABBOTT: PRODUCT APPROVALS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 245 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 246 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 247 EUROSETS: COMPANY OVERVIEW
  • TABLE 248 EUROSETS: PRODUCTS OFFERED
  • TABLE 249 SPECTRUM MEDICAL: COMPANY OVERVIEW
  • TABLE 250 SENKO MEDICAL INSTRUMENT MFG. CO., LTD.: COMPANY OVERVIEW
  • TABLE 251 CHALICE MEDICAL LTD.: COMPANY OVERVIEW
  • TABLE 252 MAGASSIST CO., LTD.: COMPANY OVERVIEW
  • TABLE 253 BRAILE BIOMEDICA: COMPANY OVERVIEW
  • TABLE 254 GIZMOMED PRIVATE LIMITED: COMPANY OVERVIEW
  • TABLE 255 ORIGEN BIOMEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 256 ABIOMED: COMPANY OVERVIEW
  • TABLE 257 ANDOCOR: COMPANY OVERVIEW
  • TABLE 258 JIANGSU STMED TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 259 CARDIOQUIP: COMPANY OVERVIEW
  • TABLE 260 CBM LIFEMOTION: COMPANY OVERVIEW
  • TABLE 261 CHANGZHOU KANGXIN MEDICAL INSTRUMENTS: COMPANY OVERVIEW
  • TABLE 262 GENTHERM: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 ECMO MACHINES MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 ECMO MACHINES MARKET: RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION OF GETINGE AB, 2024
  • FIGURE 9 ECMO MACHINES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION, 2024
  • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2025-2030
  • FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 12 ECMO MACHINES MARKET: TOP-DOWN APPROACH
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 ECMO MACHINES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 ECMO MACHINES MARKET, BY MODALITY, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 ECMO MACHINES MARKET, BY PATIENT TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 ECMO MACHINES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 ECMO MACHINES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 GEOGRAPHICAL SNAPSHOT OF ECMO MACHINES MARKET
  • FIGURE 20 GROWING DEMAND FOR INTEGRATED MULTIFUNCTIONAL DEVICES AND EXPANDING ACCESS TO ADVANCED ICUS IN UNDERSERVED REGIONS TO DRIVE MARKET GROWTH
  • FIGURE 21 COMPONENTS SEGMENT TO ACCOUNT FOR LARGEST SHARE OF APAC MARKET IN 2024
  • FIGURE 22 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 23 NORTH AMERICA TO DOMINATE ECMO MACHINES MARKET
  • FIGURE 24 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 25 ECMO MACHINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 ECMO MACHINES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 27 AVERAGE SELLING PRICE TREND OF ECMO MACHINES, BY REGION, 2022-2024 (USD)
  • FIGURE 28 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND DISTRIBUTION PHASES
  • FIGURE 29 ECMO MACHINES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 30 ECMO MACHINES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 31 ECMO MACHINES MARKET: INVESTMENT AND FUNDING SCENARIO, 2019-2023
  • FIGURE 32 ECMO MACHINES MARKET: VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023
  • FIGURE 33 ECMO MACHINES MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023 (USD MILLION)
  • FIGURE 34 ECMO MACHINES MARKET: PATENT ANALYSIS, JANUARY 2015-JULY 2025
  • FIGURE 35 ECMO MACHINES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP TWO PRODUCTS
  • FIGURE 37 KEY BUYING CRITERIA FOR TOP TWO PRODUCTS
  • FIGURE 38 NORTH AMERICA: ECMO MACHINES MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: ECMO MACHINES MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN ECMO MACHINES MARKET, 2020-2024 (USD MILLION)
  • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ECMO MACHINES MARKET (2024)
  • FIGURE 42 ECMO MACHINES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 43 ECMO MACHINES MARKET: COMPANY FOOTPRINT
  • FIGURE 44 ECMO MACHINES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 45 EV/EBITDA OF KEY VENDORS
  • FIGURE 46 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 47 ECMO MACHINES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 48 GETINGE: COMPANY SNAPSHOT
  • FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 51 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT
  • FIGURE 52 LIVANOVA PLC: COMPANY SNAPSHOT
  • FIGURE 53 NIPRO: COMPANY SNAPSHOT
  • FIGURE 54 WEIGAO GROUP CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 55 ABBOTT: COMPANY SNAPSHOT
  • FIGURE 56 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT